Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR. (Q54605761)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Karl-Friedrich Becker

9

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

1

object named as

Daniela Berg

1 reference

Europe PubMed Central

1 June 2018

Katharina Malinowsky

3

object named as

Katharina Malinowsky

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

author name string

Claudia Wolff

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Kai Tran

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Axel Walch

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Holger Bronger

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Tibor Schuster

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Heinz Höfler

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

publication date

1 January 2012

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Journal of Cellular Physiology

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

227

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

204-212

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

uPAR: a versatile signalling orchestrator

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Issues and progress with protein kinase inhibitors for cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Protein microarrays: molecular profiling technologies for clinical specimens

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Protein microarrays: meeting analytical challenges for clinical applications.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Detection of urokinase plasminogen activator receptor and c-erbB-2 in sera of patients with breast and ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

The predictive value of HER2 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22718

21 January 2018

Identifiers

10.1002/JCP.22718

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21391216

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54605761&oldid=1283473189"